Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1753–1776 of 2,478 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tissue Control Group Clear all

Conditions: Liver Fibrosis, Alpha-1 Antitrypsin Deficiency, AAT Deficiency, AATD
Interventions: Abdominal ultrasound, History and physical, Intravenous catheter, Blood draw, Liver questionnaire, Liver Biopsy, Midazolam, Fentanyl, Lidocaine, Acetaminophen, Lorazepam, Oxycodone/Acetaminophen, Ondansetron; Device · Procedure · Other + 1 more
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 70 Years
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Hypertrophic Scar
Interventions: STP705, Placebo; Drug
Lead sponsor: Sirnaomics; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cypress, California

Conditions: Seroma
Interventions: ARISTA; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Overweight and Obesity, Hyperandrogenemia, Insulin Resistance
Interventions: Mediterranean-based, carbohydrate restricted, calorie reduced diet; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Gastro-Oesophageal Cancer
Interventions: Regorafenib, Nivolumab, Docetaxel, Paclitaxel, Irinotecan, Trifluridine/Tipracil; Drug · Biological
Lead sponsor: Australasian Gastro-Intestinal Trials Group; Network
Eligibility: 18 Years and older
Enrollment: 462 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 6
States / cities: Scottsdale, Arizona • Los Angeles, California • Sioux City, Iowa + 3 more

Conditions: Pain With Paracervical Block, Pain With Gynecology Procedure, Pain
Interventions: Num Vapocoolant Spray, Placebo; Device · Other
Lead sponsor: Queen's Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Hypertension, Obesity
Interventions: Neuropeptide Y; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 55 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Fibroid Uterus, Abnormal Uterine Bleeding, Myoma;Uterus
Interventions: Tranexamic Acid, Placebos; Drug
Lead sponsor: Eastern Virginia Medical School; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Infection, Hand Injury Wrist, Hand Injuries, Hand Injuries and Disorders, Hand Arthritis
Interventions: Systemic IV Vancomycin, Bier Block, Vancomycin; Drug · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Failed or Difficult Intubation
Interventions: 3D Laser Scanning of the Head, Measurements and Digital Photo's of the head, neck and Mouth, Ultrasound Exam of the Tongue; Procedure
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 70 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Anxiety Disorders, Major Depressive Disorder
Interventions: Attention Bias Modification Training, Fluoxetine, Cognitive Behavioral Therapy; Behavioral · Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 8 Years to 65 Years
Enrollment: 3,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2029
U.S. locations: 2
States / cities: Bethesda, Maryland • College Park, Maryland

Conditions: Breast Cancer
Interventions: Partial mastectomy plus additional Shave Margin, Partial mastectomy; Procedure
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 9
States / cities: Loma Linda, California • Lakeland, Florida • Troy, Michigan + 6 more

Conditions: Ocular GVHD
Interventions: corneal sensation test; Diagnostic Test
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Staphylococcus Aureus Infection
Interventions: Mupirocin + Nozin + chlorhexidine gluconate, Education + Household supplies; Combination Product · Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Whiteriver, Arizona

Conditions: Hypoglycemia, Type 1 Diabetes
Interventions: Saline, C-peptide; Other · Biological
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 40 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Type 2 Diabetes Mellitus
Interventions: Regular Human Insulin, Placebo; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 50 Years to 85 Years
Enrollment: 289 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Allergic Conjunctivitis
Interventions: K-Lens (generic name not established) and Ketotifen, Placebo Lens; Device
Lead sponsor: Vistakon Pharmaceuticals; Industry
Eligibility: 8 Years and older
Enrollment: 310 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 3
States / cities: Gardena, California • North Andover, Massachusetts • Memphis, Tennessee

Conditions: Leukemia, Lymphoma, Graft Versus Host Disease
Interventions: cyclosporine, cyclosporine and methotrexate; Drug
Lead sponsor: Baxalta now part of Shire; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2003
U.S. locations: 12
States / cities: Los Angeles, California • Jacksonville, Florida • Atlanta, Georgia + 9 more

Conditions: Osteoarthritis
Interventions: Ropivacaine infiltration and saline infusion., Ropivacaine infiltration and infusion., Normal Saline; Procedure
Lead sponsor: Trinity Health Of New England; Other
Eligibility: 18 Years to 80 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Obesity and Overweight, Dysbiosis
Interventions: Watermelon, Belvita Breakfast Sandwich + 12 oz Water; Other
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Cancer
Interventions: Brief Motivational Intervention; Behavioral
Lead sponsor: Stony Brook University; Other
Eligibility: Not listed
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Sleep, Blood Pressure
Interventions: Sleep Restriction; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 64 Years
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Vitamin D Deficiency Disease
Interventions: Vitamin D3; Dietary Supplement
Lead sponsor: Madigan Army Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Parkinson Disease
Interventions: Social Cycling Group, coaching calls, No coaching calls; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 45 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Search by objective public record fields.

Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)

A Randomized Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Subjects With Hypertrophic Scar

Arista for ALT Donor Sites to Reduce Drain Output

Evaluating the Influence of Diet-induced Weight Loss on Fat (Adipose) Tissue's Insulin Sensitivity and Testosterone Synthesis in Women With Overweight or Obesity, Insulin Resistance, and Hyperandrogenemia

RegoNivo vs Standard of Care Chemotherapy in AGOC

Applying Num Vapocoolant Spray to Cervix Before Paracervical Block to Decrease Pain During Gynecology Procedures

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies

Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration

Three-dimensional Craniofacial Phenotyping of Patients With Difficult Airway

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Shave Margins vs. Standard Partial Mastectomy in Breast Cancer Patients

The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients

Staph Intervention for Effective Local Defense

Effect of C-peptide on Hypoglycemic Counterregulation

Memory Aid by Intranasal Insulin in Diabetes (MemAID)

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation

Local Anesthetic Infiltration and Infusion for Pain Control After Hip Replacement

Effect of Watermelon on Gut and Cardiometabolic Health

Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors

Sleep and Social Experiences Study 2

Vitamin D Supplementation in Warfighters

In-home Cycling for Individuals With PD: Effectiveness